The health care sector in Saudi Arabia receives an average of 16.5% of the government’s annual budget, reflecting its importance to socio-economic development. The Covid-19 pandemic placed significant pressure on health care systems worldwide, yet the intensified throughput allowed governments to identify weaknesses in their health services and supply chains. Saudi Arabia’s substantial sovereign reserves have seen it emerge from the worst of the pandemic in a strong position to remedy the vulnerabilities exposed by the unprecedented events of 2020-22. Moving forwards, the government plans to increase efforts to create an integrated, high-quality, value-based health care system. Public-private partnerships are targeted at strengthen specific areas of health care infrastructure, while investment in research and development capacity is set to increase.
This chapter contains an interview with Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority; and Fahad Al Shebel, CEO, the National Unified Procurement.
Health
Chapter | Health & Life Sciences from The Report: Saudi Arabia 2022
Displaying 1 - 6 of 1326
The economy of Kuwait has long been underpinned by the production and export of crude oil. Although the rise in energy prices in 2021-22 boosted government revenue and macroeconomic stability, the Covid-19 pandemic, which preceded the commodity price boom, underscored the risk of over-reliance on an industry subject to fluctuating global demand. This has created fresh impetus for economic diversification, with robust public finances providing a strong platform to...
After a surge in uptake during the Covid-19 pandemic, the telehealth industry is courting new investment to further innovation and increase access to care in emerging markets.
Interviews & Viewpoints | Fahad Al Shebel, CEO, National Unified Procurement Company (NUPCO): Interview from The Report: Saudi Arabia 2022
Considering the impact of the Covid-19 pandemic, which strategies are expected to underpin the development of the local health sector?
Interviews & Viewpoints | Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority (SFDA): Interview from The Report: Saudi Arabia 2022
To what extent has the Covid-19 pandemic impacted medical innovation and related regulatory processes in Saudi Arabia?
Articles & Analysis | Saudi Arabia prioritising investment to improve and modernise health care from The Report: Saudi Arabia 2022
The health care sector in Saudi Arabia receives an average of 16.5% of the government’s annual budget, reflecting its importance to socio-economic development. The Covid-19 pandemic placed significant pressure on health care systems worldwide, yet the intensified throughput allowed governments to identify weaknesses in their health services and supply chains. Saudi Arabia’s...
Articles & Analysis | Saudi Arabia optimising pharmaceutical manufacturing and supply chains from The Report: Saudi Arabia 2022
Two key entities have been central to the recalibration and fortification of the medical supply chain in Saudi Arabia. The National Unified Procurement Company (NUPCO) is responsible for medical supplies and equipment procurement, and supply chain regulation; and the Saudi Food and Drug Authority (SFDA) regulates and monitors foods, drugs, medicines, and diagnostic devices....